HEATHER LUPOLE: Open Payments
NPI 1770081291 · MILLERSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,433 in 82 payments from 21 companies in 2025. Trend: 2023 $688 · 2024 $1,184 · 2025 $1,433
Food & beverage: $1,433
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $221 |
| ABBVIE INC. | 14 | $212 |
| Lilly USA, LLC | 14 | $194 |
| AstraZeneca Pharmaceuticals LP | 7 | $154 |
| PFIZER INC. | 5 | $91 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Exact Sciences Corporation | 3 | $63 |
| Smith+Nephew, Inc. | 2 | $55 |
| Dexcom, Inc. | 2 | $46 |
Products named: MOUNJARO, Ozempic, QULIPTA, AIRSUPRA, JARDIANCE, Wegovy, REXULTI, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
